Another major limitation of our study is that the sequencing of MMR genes to determine which patients had Lynch syndrome was not performed as part of this study, which may have identified additional correlates with treatment outcomes and provided additional insights into the nature of MSI [30]. This evidence concerns the gene MRC1 and Lynch syndrome.